Trichomonas Infection
(TRICK-oh-MOE-nass)

• Morbidity and Mortality Weekly Report (MMWR)
• Additional Information

Morbidity and Mortality Weekly Report (MMWR)

• Sexually Transmitted Diseases Treatment Guidelines 2002 (May 10, 2002 / 51(RR-6); 1-84)
• 1989 Sexually Transmitted Diseases Treatment Guidelines (September 01, 1989 / 38(S-8);i-xi,1-43)
• 1998 Guidelines for Treatment of Sexually Transmitted Diseases (January 23, 1998 / 47(RR-1);1-118)

Additional Information

• Petrin, D., Delgaty, K., Bhatt, R. and Garber, G. 1998. Clinical and microbiological aspects of Trichomonas vaginalis. Clin. Microbiol Rev. 11:300-317.
• Pearlman, M.D., Yashar, C., Ernst, S., and Solomon, W. 1996. An incremental dosing protocol for women with severe vaginal trichomoniasis and adverse reactions to metronidazole. Am. J. Obstet. Genecol. 174:934-936.
• Smith, L.M., Wang, M., Zangwill, K., Yeh, S. 2002. Trichomonas vaginalis infection in a premature newborn. J. Perinatol. 22:502-3.
• Crowell, A. L., K. A. Sanders-Lewis, and W. E. Secor. 2003. In vitro comparison of metronidazole and tinidazole activity against metronidazole resistant strains of trichomonas vaginalis. Antimicrob. Agents Chemother. 47:1407-1409.

Trichomonas Infection

Trichomonas Infection